Prevalence of resistant hypertension in non-elderly adults: Prospective study in a clinical setting

Arquivos Brasileiros de Cardiologia

Volumn 99, Issue 1, 2012, Pages 630-635

  Massierer, Daniela ^a   Oliveira, Ana Claudia Tonelly ^a   Steinhorst, Ana Maria ^a   Gus, Miguel ^a   Ascoli, Aline Maria ^a   Gonçalves, Sandro Cadaval ^a   Moreira, Leila Beltrami ^a   Correa, Vicente ^a   Nunes, Gerson ^a   Fuchs, Sandra Costa ^a   Fuchs, Flávio Danni ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Hypertension; Medication adherence; Prevalence; White coat hypertension

Indexed keywords

DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PREVALENCE; PROSPECTIVE STUDY; RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 84866029094     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2012005000051     Document Type: Article

References (17)

1. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5):963-75.
2. Foguet Q, Marti H, Elosua R, Sala J, Masia R, Vazquez S, et al. Hypertension confirmation and blood pressure control rates in epidemiological surveys. Eur J Cardiovasc Prev Rehabil. 2008;15(3):263-9.
3. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11-9.
4. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303(20):2043-50.
5. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403-19.
6. McAdam-Marx C, Ye X, Sung JC, Brixner DI, Kahler KH. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. Clin Ther. 2009;31(5):1116-23.
7. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14(12):1263-9.
8. Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168(21):2340-6.
9. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57(5):898-902.
10. Fuchs FD, Maestri MK, Bredemeier M, Cardozo SE, Moreira FC, Wainstein MV, et al. Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens. 1995;9(7):547-51.
11. Fuchs FD, Gus M, Moreira WD, Moreira LB, Moraes RS, Rosito GA, et al. Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort. J Hypertens. 1997;15(7):783-92.
12. Gonçalves CB, Moreira LB, Gus M, Fuchs FD. Adverse events of bloodpressure-lowering drugs: evidence of high incidence in a clinical setting. Eur J Clin Pharmacol. 2007;63(10):973-8.
13. Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/ Sociedade Brasileira de Nefrologia. VI Diretrizes brasileiras de hipertensão. Arq Bras Cardiol. 2010;95(1 supl.1):1-51.
14. Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007;132(6):1858-62.
15. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
16. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57(6):1076-80.
17. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18(12 Pt 1):1534-40.